Cargando...

Biologic targeting in the treatment of inflammatory bowel diseases

The etiology of inflammatory bowel disease (IBD) has not yet been clarified and immunosuppressive agents which nonspecifically reduce inflammation and immunity have been used in the conventional therapies for IBD. Evidence indicates that a dysregulation of mucosal immunity in the gut of IBD causes a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bosani, Matteo, Ardizzone, Sandro, Porro, Gabriele Bianchi
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2009
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726060/
https://ncbi.nlm.nih.gov/pubmed/19707398
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!